Literature DB >> 21616114

Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing.

D Lutringer-Magnin1, J Kalecinski, G Barone, Y Leocmach, V Regnier, A C Jacquard, B Soubeyrand, P Vanhems, F Chauvin, C Lasset.   

Abstract

Acceptance of the Human Papillomavirus (HPV) vaccine by targeted populations will depend to a large extent on its acceptability among physicians. We examined the perceptions, attitudes and practices of general practitioners (GPs) in relation to HPV vaccination. From November 2007 to April 2008, a cross-sectional survey was carried out among a representative 5% sample of GPs in the large Rhône-Alpes region of France. Both quantitative (self-administered questionnaire) and qualitative (interview) approaches were used. During the month preceding the survey, 75.6% of the 279 GPs who responded had given at least one HPV vaccination and 47.6% had given a vaccination at the routine target age of 14 years. Overall, 80.8% of GPs reported a favourable opinion about HPV vaccination, 17.4% were uncertain and 1.8% were opposed. The main justification for a favourable opinion related to the public health benefits of the HPV vaccination (cited by 60% of those favouring vaccination). The main justification for an "opposed or uncertain" opinion was the too recent introduction of the vaccine (cited by 43.4%). The major difficulties in providing HPV vaccination were patients' concerns about potential side effects (cited by 37% of the respondents) and the target age of 14 years (28.9%). Interviews suggested that the concern about age may relate to the need, as perceived by GPs, to discuss sexually transmitted infections with adolescent patients. A favourable opinion about HPV vaccination was associated with seeing more female patients per week, younger age, and GPs' intention to recommend hepatitis B vaccination. This representative survey of GPs in a major region of France finds a favourable opinion about the HPV vaccine and widespread use of it, despite some concerns that the recent introduction of the vaccine means that we do not yet fully understand the potential for side effects and about the recommended target age of recipients.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21616114     DOI: 10.1016/j.vaccine.2011.05.006

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Practices and opinions regarding HPV vaccination among French general practitioners: evaluation through two cross-sectional studies in 2007 and 2010.

Authors:  Christine Lasset; Julie Kalecinski; Véronique Régnier; Giovanna Barone; Yann Leocmach; Philippe Vanhems; Franck Chauvin; Delphine Lutringer-Magnin
Journal:  Int J Public Health       Date:  2014-04-23       Impact factor: 3.380

2.  Factors influencing the recommendation of the Human Papillomavirus vaccine by South African doctors working in a tertiary hospital.

Authors:  Muhammad Ehsanul Hoque
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

3.  Managing uncertainty: healthcare professionals' meanings regarding the HPV vaccine.

Authors:  Irina Todorova; Anna Alexandrova-Karamanova; Yulia Panayotova; Elitsa Dimitrova; Tatyana Kotzeva
Journal:  Int J Behav Med       Date:  2014-02

4.  Human Papillomavirus vaccination in general practice in France, three years after the implementation of a targeted vaccine recommendation based on age and sexual history.

Authors:  Pascale Thierry; Andrea Lasserre; Louise Rossignol; Solen Kernéis; Fanette Blaizeau; Chantal Stheneur; Thierry Blanchon; Daniel Levy-Bruhl; Thomas Hanslik
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

5.  HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe.

Authors:  Emilie Karafillakis; Clarissa Simas; Caitlin Jarrett; Pierre Verger; Patrick Peretti-Watel; Fadia Dib; Stefania De Angelis; Judit Takacs; Karam Adel Ali; Lucia Pastore Celentano; Heidi Larson
Journal:  Hum Vaccin Immunother       Date:  2019-02-20       Impact factor: 3.452

6.  French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 - 18 year old daughters: a quantitative-qualitative study.

Authors:  Julie Haesebaert; Delphine Lutringer-Magnin; Julie Kalecinski; Giovanna Barone; Anne-Carole Jacquard; Véronique Régnier; Yann Leocmach; Philippe Vanhems; Franck Chauvin; Christine Lasset
Journal:  BMC Public Health       Date:  2012-11-27       Impact factor: 3.295

7.  Disparities of perceptions and practices related to cervical cancer prevention and the acceptability of HPV vaccination according to educational level in a French cross-sectional survey of 18-65 years old women.

Authors:  Julie Haesebaert; Delphine Lutringer-Magnin; Julie Kalecinski; Giovanna Barone; Anne-Carole Jacquard; Yann Leocmach; Véronique Régnier; Philippe Vanhems; Franck Chauvin; Christine Lasset
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

8.  Acceptability of multipurpose human papillomavirus vaccines among providers and mothers of adolescent girls: A mixed-methods study in five countries.

Authors:  Nadja A Vielot; Shoshana K Goldberg; Gregory Zimet; Sara B Smith; Mary Anne McDonald; Silvina Ramos; Karen Morgan; Chan Joo Kim; Karin L Richter; Merce Peris; Kevin J Whaley; Jennifer S Smith
Journal:  Papillomavirus Res       Date:  2017-04-06

Review 9.  Cognitions and behaviours of general practitioners in France regarding HPV vaccination: A theory-based systematic review.

Authors:  Géraldine Escriva-Boulley; Olena Mandrik; Marie Préau; Rolando Herrero; Patricia Villain
Journal:  Prev Med       Date:  2020-11-07       Impact factor: 4.018

10.  Vaccination Attitudes and Experiences of Medical Doctors in Croatia amid the COVID-19 Pandemic: A Social Roles Conflict?

Authors:  Maja Miskulin; Aida Mujkic; Ivan Miskulin; Zvjezdana Lovric Makaric; Emma Kovacevic; Ljiljana Pintaric; Zeljko Pavic
Journal:  Vaccines (Basel)       Date:  2022-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.